Fair Value Calculator Fair Value Calculator
EN DE

DRONACHRYA (DRONACHRYA) Fair Value & Analysis

IN · Market cap ₹955M

D DRONACHRYA DRONACHRYA · BSE
Price₹39.79
Fair Value₹7.05
Upside-82.3%
Quality36/100
Watch DRONACHRYA for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹4.94 – ₹9.17

Fair value as of: Jul 5, 2026

From 10 valuation models · updated today

Share price +4.7% over the past month.

Price vs Fair Value (12 months)

₹91.99 ₹28.98 Fair Value ₹7.05 Jul 2025 Jul 2026

12‑month range ₹28.98 – ₹91.99 · fair‑value band ₹4.94 – ₹9.17 · the ₹39.79 price screens above the ₹7.05 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

DRONACHRYA (DRONACHRYA) currently trades at ₹39.79, while our model-based Fair Value estimate is ₹7.05 — implying the stock looks roughly 82.3% overvalued today. We read business quality at 36/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, DRONACHRYA generated revenue of ₹147M at a net margin of 2.6%. Revenue declined 33.2% year over year. It earns a return on equity of 0.6%. Net debt stands at ₹4.7M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹4.94 (bear case) to ₹9.17 (bull case); at ₹39.79, the current price sits above that range. The share trades about 57% below its 52-week high and 37% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹147M
Revenue growth (YoY) -33.2%
Net margin 2.6%
Return on equity 0.6%
Free cash flow −₹81.5M FY2026
P/E ratio 248.7
More key figures
Operating margin -89.4%
EPS (TTM) ₹0.1600
EPS growth (YoY) +30.6%
Net debt ₹4.7M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2026 · reported fiscal years

DRONACHRYA reported revenue of ₹147M in FY2026 versus ₹100K in FY2021, a compound +329.8%/yr. Reported net income was ₹3.8M in FY2026.

Revenue +329.8%/yr
FY21 ₹100K
FY22 ₹35.9M
FY23 ₹186M
FY24 ₹353M
FY26 ₹147M
Net income
FY21 −₹1.5M
FY22 ₹4.1M
FY23 ₹34.3M
FY24 ₹60.9M
FY26 ₹3.8M

Is DRONACHRYA fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "DRONACHRYA Fair Value". https://www.fairvalue-calculator.com/stock/DRONACHRYA

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is DRONACHRYA (DRONACHRYA) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹7.05 versus a price of ₹39.79 — about −82% (overvalued). Model-based estimate, not financial advice.
What is the fair value of DRONACHRYA?
Our model-based fair value for DRONACHRYA is ₹7.05 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹39.79.
What is the quality score of DRONACHRYA?
DRONACHRYA has a Quality Score of 36/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of DRONACHRYA (DRONACHRYA)?
DRONACHRYA reported trailing-twelve-month revenue of about ₹147M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of DRONACHRYA?
The net profit margin of DRONACHRYA is about 2.6%, meaning it keeps roughly 2.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.